American Society of Echocardiography

JOIN ASE
Renew
Member Log In
Donate

Membership
Advocacy
Initiatives
Education
ASE Guidelines
Journals
ASE Foundation
Resources
About

October 3, 2016 By Arissa Cooper

GE Healthcare Announces FDA Labeling Change for Use of Optison™ In Patients with Cardiac Shunts

Read release here.

Share via:

Facebook
Twitter
LinkedIn
Email
More

Filed Under: News

Recent Posts

Prep for the RPVI Examination!
The Countdown Begins: 23 Days Until ASE 2023
Now Available: 2023 Coding Connection Newsletter
Read the May Echo Magazine
Echo VOL | 12 Issue 5

Annual Meeting
ASE Learning Hub
ASE Learning Hub for Nonmembers
Connect@ASE
For Patients

Site Map

Return to top of page

Copyright © 2023 ·Executive Theme · Genesis Framework by StudioPress · WordPress · Log in

Share via

Powered by Social Snap

Copy link

CopyCopied

Powered by Social Snap

American Society of Echocardiography
The Society for Cardiovascular Ultrasound Professionals
2530 Meridian Parkway, Suite 450
Durham, NC 27713
919.861.5574

Copyright © 2023 American Society of Echocardiography